These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5425552)

  • 21. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Latest results of East African/British Medical Research Council short course chemotherapy studies.
    Heffernan JF
    Tubercle; 1975 Jun; 56(2):165. PubMed ID: 1181688
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project].
    Wen S; Su Y; Zhang F
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):357-9. PubMed ID: 9596819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis].
    Yan S; Ye H; Lin S
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New combinations of drugs for the treatment of drug-resistant tuberculosis].
    Schmelev NA
    Bull Int Union Tuberc; 1968 Dec; 41():192-3. PubMed ID: 5710248
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Jun; 32(4):572-3. PubMed ID: 5758995
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 30. Madras study of two once-weekly regimens: clinical aspects.
    Menon NK
    Bull Int Union Tuberc; 1970 Jun; 43():271-5. PubMed ID: 5425554
    [No Abstract]   [Full Text] [Related]  

  • 31. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide].
    Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H
    Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
    Kayantao D; Keïta B; Sangaré S
    Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-drug initial therapy for TB is standard treatment.
    Brennan PJ; MacGregor RR
    Pa Med; 1996 Jan; 99(1):18-9. PubMed ID: 8927398
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of a study carried out in Morocco on intermittent treatment of pulmonary tuberculosis with a bi-weekly combination of isoniazid and streptomycin adminisrered intramuscularly].
    Burzoni FJ; Durante C
    Bull Int Union Tuberc; 1968 Dec; 41():322-4. PubMed ID: 5710256
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pyrazinamide-containing initial intensive short course chemotherapy of pulmonary tuberculosis].
    Wada M
    Kekkaku; 1997 Oct; 72(10):587-95. PubMed ID: 9386358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
    Long R; Scalcini M
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879
    [No Abstract]   [Full Text] [Related]  

  • 40. [Certain aspects of new combinations of drugs for the treatment of drug-resistant tuberculosis].
    Jancík E; Novák M; Jancíková M; Tousek J; Krátký J; Feitová S; Zelenka M
    Bull Int Union Tuberc; 1968 Dec; 41():188-91. PubMed ID: 5710247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.